[Case Study] Takashi Ueda “Candidemia Requires Routine Ophthalmologic Evaluation!” (AMR Alliance Japan, November 18, 2021)
date : 11/18/2021
Tags: AMR
![[Case Study] Takashi Ueda “Candidemia Requires Routine Ophthalmologic Evaluation!” (AMR Alliance Japan, November 18, 2021)](https://hgpi.xsrv.jp/en/wp-content/uploads/sites/2/amr-cese03-2-top_ENG.jpg)
As part of the Alliance’s project to promote antimicrobial steward among medical professionals, AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has begun publishing case studies from various experts related to antimicrobial resistance.
Takashi Ueda (Department of Infection Control and Prevention, Hyogo College of Medicine Hospital) reports a case titled “Candidemia Requires Routine Ophthalmologic Evaluation!”
Case study 03
Dr. Takashi Ueda (Department of Infection Control and Prevention, Hyogo College of Medicine Hospital)
“Candidemia Requires Routine Ophthalmologic Evaluation!”
For further information, please see the case study below.
Case study 01
Dr. Keiji Okinaka (Director of Infection Control and Prevention Section, National Cancer Center Hospital East / Department of General Internal Medicine, National Cancer Center Hospital East /Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)
“A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment”
Top Research & Recommendations Posts
- [Joint Report and Recommendations] “Rebalancing Health System: Innovation and Sustainability” A Joint Global Expert Meeting convened by the CSIS and HGPI
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Research Report] 2017 Public Survey on Healthcare in Japan
- [Research Report] Public Opinion Survery on the Threat of Antimicrobial Resistance (AMR) (November 26, 2021)